Dear Sir, Coronary heart disease (CHD) is one of the leading causes of death in Japan as well as in western countries. Many genes are suspected to be involved in its aetiology [1, 2]. Most however, remain to be clarified. Nitric oxide (NO) has vasodilatation effects, and inhibits smooth muscle cell proliferation and platelet adhesion, which lead to the development of atherosclerosis [3]. Endothelial NO is formed from l-arginine by constitutively expressed endothelial NO synthase (ecNOS). Though the l-arginine-NO pathway has been implicated in contributing to the protection from developing CHD [4], an association of ecNOS gene mutations or polymorphisms with CHD had not been proved to exist. Several genetic variations in the ecNOS gene have been reported, however, scarcely any have been reported to be associated with cardiovascular diseases to our knowledge [5]. Recently, a 27-base pair (bp) repeat polymorphism in intron 4 of the ecNOS gene (ecNOS 4a/a genotype) was shown to be associated with a smoking-dependent risk of coronary artery disease [6]. This genotype was also associated with a history of myocardial infarction. These observations raise the possibility that this polymorphism is associated with CHD in noninsulin-dependent diabetes mellitus (NIDDM), which is a potent risk factor for the development of atherosclerosis and CHD besides smoking. We investigated 164 unrelated Japanese patients with NIDDM (89 males/75 females) to see whether this polymorphism is associated with CHD. Of these, 42 (22 males/20 females) had a past history of acute myocardial infarction or had angiographically proven CHD with more than 75 % stenosis in at least one of the major coronary arteries (CHD + group), and 122 (67 males/55 females) who were apparently free from CHD on normal electrocardiograph at rest (CHD -group). Age (CHD +; mean ± SD; 63.7 ± 8.8 years, CHD -: 61.8 ± 7.7 years: p = 0.17), sex (p = 0.78), body mass index (26.3 ± 4.2, 24.8 ± 4.0 kg/m 2 : p = 0.053), duration of diabetes (14.1 ± 6.5, 12.7 ± 7.7 years: p = 0. The polymorphism was identified by polymerase chain reaction followed by electrophoresis on 6 % polyacrylamide gel. The used primers were, sense primer: 5 ¢-AGGCCCTATGG-TAGTGCCTT-3 ¢ (5111-5130 bp), anti-sense: 5 ¢-TCTCTTAGTGCTGTGGTCAC-3 ¢ (5530-5511 bp). Genetic determination (Table 1) revealed that among 42 CHD + patients, 31 had b/b (insertion +/insertion +) isoform and 11 had b/a (insertion +/insertion -) and none had a/a (insertion -/insertion -) isoform. Among 122 CHD -patients, 103 patients had b/b isoform and 19 patients had b/a and none had a/a isoform. Neither the distribution of the ecNOS genotypes nor allele frequencies were significantly different between the CHD + and CHD -groups. A/a genotype, which is associated with CHD in Caucasians, proved to be rare in the analysed Japanese patients. From these observations, we conclude that 27-bp repeat polymorphism in intron 4 of ecNOS gene is unlikely to play a major role in the pathogenesis of CHD among Japanese patients with NIDDM. And rarity of a/a genotype may contribute to the low incidence of CHD in Japanese patients with NIDDM.
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Primer pairs to these genes were then optimized for mapping onto the Stanford G3 and Genebridge GB4 radiation hybrid panels (Research Genetics, Huntsville, Ala., USA). Marker retention data was analysed using RHMAP Version 2.01 for the G3 data or the Whitehead Institute-MIT Center for Genome Research radiation hybrid mapping web sever for the GB4 data. Distance relationships to nearby polymorphic markers were established using the statistical package RHMAPPER and RH2PT [2, 3] .
Candidate gene markers in Table 1 are those with reported heterozygosities greater than 60 % and estimated to be not more than two megabases (Mb) (66.7 centirays [Cr] ) from the candidate gene based on two-point analysis of Stanford G3 panel retention data. In about half of the cases, markers were determined to be within 1 Mb (33.3 cR) of the gene. For some loci, approximate distances from markers had to be inferred by comparing both G3 and GB4 data because of gaps in the map data available from the European Bioinformatics Institute (EBI) [4] . In addition, a marker was nominated for a candidate gene only after one or more of the following conditions was met: 1) proximity to the marker was confirmed by an independent sequence tag site (STS) within the gene; 2) proximity to the marker was confirmed by an independent radiation hybridization (RH) panel; or 3) the candidate gene and nominated marker were part of a linkage group supported with a two-locus logarithm of odds (LOD) score of at least three using RH2PT.
Incorporation of NIDDM candidate gene markers, such as those reported here, within a genome scan will ensure that genes which play a role in insulin action, obesity, energy and glucose metabolism are evaluated for their role in genetic susceptibility to the disease. RH analysis offers a rapid and precise way to localize genes with respect to anonymous markers or other genes and thus offers an advantage over methods such as meiotic mapping or fluorescent in situ hybridization (FISH). Even when polymorphic markers are known to exist within the candidate gene, such as with RAD and hexokinase II, it is often desirable to identify other nearby markers that can be more conveniently included within a genome scan set or that are more informative in a particular study population. RH analysis offers a rapid method of identifying these markers.
Analysis of 20 NIDDM candidate genes by RH analysis has led to the identification of a polymorphic marker within 2cM (~2Mb) of each gene. A highly informative marker to leptin has also been identified. These markers will prove to be important tools in the ongoing search for diabetes susceptibility loci. 
